Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Collaborative Learning of Semi-Supervised Segmentation and Classification for Medical Images
280
Zitationen
7
Autoren
2019
Jahr
Abstract
Medical image analysis has two important research areas: disease grading and fine-grained lesion segmentation. Although the former problem often relies on the latter, the two are usually studied separately. Disease severity grading can be treated as a classification problem, which only requires image-level annotations, while the lesion segmentation requires stronger pixel-level annotations. However, pixel-wise data annotation for medical images is highly time-consuming and requires domain experts. In this paper, we propose a collaborative learning method to jointly improve the performance of disease grading and lesion segmentation by semi-supervised learning with an attention mechanism. Given a small set of pixel-level annotated data, a multi-lesion mask generation model first performs the traditional semantic segmentation task. Then, based on initially predicted lesion maps for large quantities of image-level annotated data, a lesion attentive disease grading model is designed to improve the severity classification accuracy. Meanwhile, the lesion attention model can refine the lesion maps using class-specific information to fine-tune the segmentation model in a semi-supervised manner. An adversarial architecture is also integrated for training. With extensive experiments on a representative medical problem called diabetic retinopathy (DR), we validate the effectiveness of our method and achieve consistent improvements over state-of-the-art methods on three public datasets.
Ähnliche Arbeiten
Optical Coherence Tomography
1991 · 13.570 Zit.
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 · 7.207 Zit.
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
2014 · 6.682 Zit.
YOLOv3: An Incremental Improvement
2018 · 5.881 Zit.
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 · 5.798 Zit.